IonQ, Inc.

IonQ builds trapped-ion quantum computers and sells access to them through AWS Braket, Azure Quantum and its own cloud — one of the two or three names in a genuinely early-stage industry. The stock has been in a slow, painful bleed: seven consecutive red weekly candles, back to the same price as 18 months ago even though the operating business has clearly moved forward.

• The revenue trajectory is real for a pre-commercial category: revenue grew 7.5x YoY off a tiny base to $65M, and the guidance range of $260-270M for the year would multiply the top line another 4x from where it started — the machines are printing early revenue that quantum skeptics didn't think existed.
• The balance sheet is the reason IonQ can wait: about $3.1B of cash and only nominal debt means the runway is measured in many years, not many quarters, and the pending SKYT acquisition and the DOE Genesis Mission partnership add credible non-dilutive revenue paths.
• The valuation is the real problem, not the business: at 113x sales the stock still asks the market to pay for quantum working commercially, and every quarter that goes by without a real commercial-scale customer story shrinks the pool of buyers willing to underwrite that premium.
• The insider tape is a slow drip: three director sales at about $150-210K each on June 22 with no offsetting buys — small in dollars but the direction is consistent, and it lands into a chart that is already broken with the stock 36% below its 50-day and in the bottom 15% of the 52-week range.

The August 5 Q2 print is the near-term line: a firm reaffirmation of the $260-270M guide plus a named commercial customer restarts the story; a soft print or a hedged guide with the SKYT deal still pending would confirm the '7 red candles' tape and send the stock into the mid-$20s.